Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat
- PMID: 7979987
- DOI: 10.1007/BF01311180
Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat
Abstract
One segment of the negative regulatory region of the human immunodeficiency virus long terminal repeat (HIV-LTR), nucleotides -273 to -255, is homologous to positive response elements for interleukin-2 and glucocorticoids. We demonstrate that this sequence, referred to as purine-rich response element (PRRE), acts as a classic enhancer in the context of a heterologous promoter, but serves as a functional repressor in the intact provirus, binding (a) cellular factor(s). These data suggest that certain DNA response elements in the HIV LTR serve as negative regulators only in the context of the intact LTR, presumably through interactions with other transcriptional factors, a phenomenon that might be exploited to interfere with viral gene transcription.
Similar articles
-
A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.Nucleic Acids Res. 2000 Feb 1;28(3):663-8. doi: 10.1093/nar/28.3.663. Nucleic Acids Res. 2000. PMID: 10637316 Free PMC article. Review.
-
Characterization and purification of a novel transcriptional repressor from HeLa cell nuclear extracts recognizing the negative regulatory element region of human immunodeficiency virus-1 long terminal repeat.J Biol Chem. 1992 Dec 15;267(35):24948-52. J Biol Chem. 1992. PMID: 1459999
-
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.Virology. 1992 Jan;186(1):133-47. doi: 10.1016/0042-6822(92)90067-y. Virology. 1992. PMID: 1727595
-
Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.J Gen Virol. 1998 Feb;79 ( Pt 2):239-46. doi: 10.1099/0022-1317-79-2-239. J Gen Virol. 1998. PMID: 9472608
-
A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence.J Biol Chem. 1992 Feb 15;267(5):3389-95. J Biol Chem. 1992. PMID: 1737792
Cited by
-
A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.Nucleic Acids Res. 2000 Feb 1;28(3):663-8. doi: 10.1093/nar/28.3.663. Nucleic Acids Res. 2000. PMID: 10637316 Free PMC article. Review.
-
Perspective: Quality Versus Quantity; Is It Important to Assess the Role of Enhancers in Complex Disease from an In Vivo Perspective?Int J Mol Sci. 2020 Oct 23;21(21):7856. doi: 10.3390/ijms21217856. Int J Mol Sci. 2020. PMID: 33113946 Free PMC article.
-
Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor-Activator Target Sequence of 5'-LTR.Front Immunol. 2018 Jan 4;8:1924. doi: 10.3389/fimmu.2017.01924. eCollection 2017. Front Immunol. 2018. PMID: 29354130 Free PMC article.